Local inhibition of angiogenesis combined with repeated blood clot embolization induces chronic thromboembolic pulmonary hypertension in rabbits

R. Quarck (Leuven, Belgium), A. Wagenaar (Leuven, Belgium), B. Tielemans (Leuven, Belgium), P. Mendes-Ferreira (Leuven, Belgium), F. Perros (Le Plessis-Robinson, France), P. Dorfmuller (Le Plessis-Robinson, France), C. Belge (Leuven, Belgium), M. Delcroix (Leuven, Belgium)

Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Session: Chronic thromboembolic pulmonary hypertension
Session type: Oral Presentation
Number: 4947
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-posterWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Quarck (Leuven, Belgium), A. Wagenaar (Leuven, Belgium), B. Tielemans (Leuven, Belgium), P. Mendes-Ferreira (Leuven, Belgium), F. Perros (Le Plessis-Robinson, France), P. Dorfmuller (Le Plessis-Robinson, France), C. Belge (Leuven, Belgium), M. Delcroix (Leuven, Belgium). Local inhibition of angiogenesis combined with repeated blood clot embolization induces chronic thromboembolic pulmonary hypertension in rabbits. 4947

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Repeated embolization and fibrinolysis inhibition induce chronic thromboembolic pulmonary hypertension in rabbits
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019




Surgical treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 735-742
Year: 2013



Systemic oxygenation affects post-transplantation edema formation and pulmonary artery hypertension in an ex vivo animal model
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013



Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010



Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007


Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
Source: Eur Respir J 2014; 44: 1275-1288
Year: 2014



Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009


Chronic thromboembolic pulmonary hypertension: update 2004
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=243
Year: 2004

Experimental study of thrombolytic effects in a canine models of pulmonary thromboembolism induced by autologous radioactive blood clots
Source: Eur Respir J 2003; 22: Suppl. 45, 271s
Year: 2003

Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010


Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003



The long-term prognostic value of extracted thrombus and hemodynamics and in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

HDAC inhibitor quisinostat reduces pulmonary vascular remodeling in experimentally induced pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020


MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019


Lower than expected pulsatile pulmonary arterial load in a thromboembolic pulmonary hypertension model
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018


The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009